ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma

Figure 2

ABL1 protein expression varies in various subgroups of HCC patients based on patient age, sex, cancer stage, and TP53 mutation status. (a) Box plot shows the relative expression of ABL1 in different age groups of HCC patients. (b) Box plot shows the relative expression of ABL1 in different sex groups of HCC patients. (c) Box plot shows the relative expression of ABL1 in the cancer stage group of HCC patients. (d) Box plot shows the relative expression of ABL1 in the TP53 mutation status group of HCC patients.

(a)

(b)

(c)

(d)